Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Pell City

Colorado Springs

Lakewood

Littleton

Hollywood

Jacksonville

New Port Richey

Winter Park

Chicago

Louisville

Metairie

Monroe

Annapolis

Towson

Chesterfield

West Bloomfield

Rochester

Raleigh

Cincinnati

Cleveland

Lancaster

Germantown

Norfolk

Seattle

Concord

Box Hill

Footscray

Parkville

Adelaide

Bankstown

Clayton

Fitzroy

Fremantle

Garran

Vienna

Bonheiden

Brussels

Ghent

Leuven

Liège

Roeselare

Belo Horizonte

Curitiba

Goiânia

Porto Alegre

Rio de Janeiro

Santo André

Santos

São Paulo

Edmonton

Kelowna

Winnipeg

Hamilton

Kingston

London

Toronto

Calgary

Santiago

Viña del Mar

Hradec Králové

Hradek Kralove

Prague

Ústí nad Orlicí

Zlín

Tallinn

Tartu

Mikkeli

Berlin

Frankfurt

Freiburg im Breisgau

Homburg

Jena

Kiel

München

Ulm

Wilhelmshaven

Budapest

Győr

Nagykanizsa

Szeged

Szombathely

Beersheba

Haifa

Holon

Jerusalem

Kfar Saba

Petha Tikva

Rehovot

Tel Aviv

Ẕerifin

Bologna

Padua

Roma

Riga

Valmiera

Milford

Newton

Auckland

Christchurch

Hamilton

Częstochowa

Lodz

Warsaw

Wroclaw

Bucharest

Cluj-Napoca

Constanța

Kazan'

Moscow

Saint Petersburg

Dniepropetrovsk

Donetsk

Kiev

Kyiv

Lviv

Simferopol